TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ONTOZRY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

ONTOZRY

ST13

US500000079299705

Class

5

Filing

79299705

Registration

6473512

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

25

Latest update

11/27/2024

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

11/05/2020

Registration date

09/07/2021

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/07/2021

Last transaction

11/27/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

KR

Examiner

MAHMOUDI, MARIAM

Law office

M60

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

SK BIOPHARMACEUTICALS CO., LTD.

Representatives

Hun Joon Kim LEX IP Meister, PLLC.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of epilepsy; pharmaceutical products for the treatment of epilepsy; chemical preparations for pharmaceutical purposes for the treatment and relief of epilepsy; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations for the prevention of disorders of the nervous system; psychotropics; soporifics; pain relief preparations; pharmaceutical preparations for the treatment of diseases of the endocrine system; pharmaceutical preparations for treating metabolic disorders; pharmaceutical preparations for the treatment of multiple sclerosis; medicated preparations for treating skin disorders; pharmaceutical preparations for the treatment of musculoskeletal disorders; pharmaceutical preparations for preventing and treating seizure; pharmaceutical preparations for the treatment of cardiovascular disease; pills for treating symptoms of dizziness; pharmaceutical preparations for the prevention of disorders of the immune system; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical products for treating respiratory diseases

Publications

History of USPTO decisions and trademark events.

25 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/27/2024

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

11/27/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/27/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/27/2024

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

03/07/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

02/15/2022

FIMP

FINAL DISPOSITION PROCESSED

02/15/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

12/07/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

09/07/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/22/2021

PUBO

PUBLISHED FOR OPPOSITION

06/22/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/02/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/17/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/17/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/17/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/17/2021

RFNT

REFUSAL PROCESSED BY IB

05/11/2021

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

04/21/2021

RFRR

REFUSAL PROCESSED BY MPU

04/21/2021

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

04/20/2021

CNRT

NON-FINAL ACTION WRITTEN

04/19/2021

DOCK

ASSIGNED TO EXAMINER

04/13/2021

MAFR

APPLICATION FILING RECEIPT MAILED

12/18/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/14/2020

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

12/10/2020

Continuous trademark protection

Get notified about every new filing that threatens ONTOZRY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.